223 related articles for article (PubMed ID: 25417052)
1. The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells.
Krüger CT; Hofmann M; Hartwig A
Arch Toxicol; 2015 Dec; 89(12):2429-43. PubMed ID: 25417052
[TBL] [Abstract][Full Text] [Related]
2. The in vitro PIG-A gene mutation assay: glycosylphosphatidylinositol (GPI)-related genotype-to-phenotype relationship in TK6 cells.
Krüger CT; Fischer BM; Armant O; Morath V; Strähle U; Hartwig A
Arch Toxicol; 2016 Jul; 90(7):1729-36. PubMed ID: 27100116
[TBL] [Abstract][Full Text] [Related]
3. Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk
Bemis JC; Avlasevich SL; Labash C; McKinzie P; Revollo J; Dobrovolsky VN; Dertinger SD
Environ Mol Mutagen; 2018 Jan; 59(1):18-29. PubMed ID: 29115020
[TBL] [Abstract][Full Text] [Related]
4. The development of an in vitro Pig-a assay in L5178Y cells.
David R; Talbot E; Allen B; Wilson A; Arshad U; Doherty A
Arch Toxicol; 2018 Apr; 92(4):1609-1623. PubMed ID: 29362862
[TBL] [Abstract][Full Text] [Related]
5. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.
Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH
Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999
[TBL] [Abstract][Full Text] [Related]
6. Applying the erythrocyte Pig-a assay concept to rat epididymal sperm for germ cell mutagenicity evaluation.
Ji Z; LeBaron MJ
Environ Mol Mutagen; 2017 Aug; 58(7):485-493. PubMed ID: 28714084
[TBL] [Abstract][Full Text] [Related]
7. Establishing a novel Pig-a gene mutation assay in L5178YTk
Wang Y; Revollo J; McKinzie P; Pearce MG; Dad A; Yucesoy B; Rosenfeldt H; Heflich RH; Dobrovolsky VN
Environ Mol Mutagen; 2018 Jan; 59(1):4-17. PubMed ID: 29098723
[TBL] [Abstract][Full Text] [Related]
8. Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody.
Kimoto T; Horibata K; Chikura S; Hashimoto K; Itoh S; Sanada H; Muto S; Uno Y; Yamada M; Honma M
Mutat Res; 2013 Aug; 755(2):126-34. PubMed ID: 23792374
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vivo genotoxicity induced by N-ethyl-N-nitrosourea, benzo[a]pyrene, and 4-nitroquinoline-1-oxide in the Pig-a and gpt assays.
Horibata K; Ukai A; Kimoto T; Suzuki T; Kamoshita N; Masumura K; Nohmi T; Honma M
Environ Mol Mutagen; 2013 Dec; 54(9):747-54. PubMed ID: 24105957
[TBL] [Abstract][Full Text] [Related]
10. Both PIGA and PIGL mutations cause GPI-a deficient isolates in the Tk6 cell line.
Nicklas JA; Carter EW; Albertini RJ
Environ Mol Mutagen; 2015 Oct; 56(8):663-73. PubMed ID: 25970100
[TBL] [Abstract][Full Text] [Related]
11. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment.
Dobrovolsky VN; Miura D; Heflich RH; Dertinger SD
Environ Mol Mutagen; 2010; 51(8-9):825-35. PubMed ID: 20857433
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats.
Revollo J; Pearce MG; Petibone DM; Mittelstaedt RA; Dobrovolsky VN
Mutagenesis; 2015 May; 30(3):315-24. PubMed ID: 25820172
[TBL] [Abstract][Full Text] [Related]
13. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.
Peruzzi B; Araten DJ; Notaro R; Luzzatto L
Mutat Res; 2010; 705(1):3-10. PubMed ID: 20034593
[TBL] [Abstract][Full Text] [Related]
14. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea.
Miura D; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH
Mutat Res; 2009; 677(1-2):86-92. PubMed ID: 19501187
[TBL] [Abstract][Full Text] [Related]
15. In vivo mutation assay based on the endogenous Pig-a locus.
Bryce SM; Bemis JC; Dertinger SD
Environ Mol Mutagen; 2008 May; 49(4):256-64. PubMed ID: 18288722
[TBL] [Abstract][Full Text] [Related]
16. Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cells.
Dobrovolsky VN; Elespuru RK; Bigger CA; Robison TW; Heflich RH
Environ Mol Mutagen; 2011 Dec; 52(9):784-94. PubMed ID: 21826740
[TBL] [Abstract][Full Text] [Related]
17. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants.
Miura D; Dobrovolsky VN; Mittelstaedt RA; Kasahara Y; Katsuura Y; Heflich RH
Environ Mol Mutagen; 2008 Oct; 49(8):622-30. PubMed ID: 18626996
[TBL] [Abstract][Full Text] [Related]
18. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression.
Kimoto T; Suzuki K; Kobayashi XM; Dobrovolsky VN; Heflich RH; Miura D; Kasahara Y
Mutat Res; 2011 Jul; 723(1):36-42. PubMed ID: 21549855
[TBL] [Abstract][Full Text] [Related]
19. CD48-deficient T-lymphocytes from DMBA-treated rats have de novo mutations in the endogenous Pig-a gene.
Dobrovolsky VN; Revollo J; Pearce MG; Pacheco-Martinez MM; Lin H
Environ Mol Mutagen; 2015 Oct; 56(8):674-83. PubMed ID: 26033714
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutation in the rat Pig-a assay: I) studies with bone marrow erythroid cells.
Revollo JR; Pearce MG; Dad A; Petibone DM; Robison TW; Roberts D; Dobrovolsky VN
Environ Mol Mutagen; 2018 Oct; 59(8):722-732. PubMed ID: 30091272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
